vs
Lantheus Holdings, Inc.（LNTH）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是世纪互联的1.1倍（$406.8M vs $362.7M），Lantheus Holdings, Inc.净利率更高（13.3% vs -10.7%，领先24.0%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $-193.1M），过去两年世纪互联的营收复合增速更高（17.4% vs 4.9%）
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
LNTH vs VNET — 直观对比
营收规模更大
LNTH
是对方的1.1倍
$362.7M
净利率更高
LNTH
高出24.0%
-10.7%
自由现金流更多
LNTH
多$274.5M
$-193.1M
两年增速更快
VNET
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.8M | $362.7M |
| 净利润 | $54.1M | $-38.7M |
| 毛利率 | 59.2% | 20.9% |
| 营业利润率 | 19.0% | 0.5% |
| 净利率 | 13.3% | -10.7% |
| 营收同比 | 4.0% | — |
| 净利润同比 | 558.8% | — |
| 每股收益（稀释后） | $0.86 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNTHVNET
| Q4 25 | $406.8M | — | ||
| Q3 25 | $384.0M | $362.7M | ||
| Q2 25 | $378.0M | — | ||
| Q1 25 | $372.8M | $309.5M | ||
| Q4 24 | $391.1M | — | ||
| Q3 24 | $378.7M | $302.2M | ||
| Q2 24 | $394.1M | $274.4M | ||
| Q1 24 | $370.0M | $262.9M |
净利润LNTHVNET
| Q4 25 | $54.1M | — | ||
| Q3 25 | $27.8M | $-38.7M | ||
| Q2 25 | $78.8M | — | ||
| Q1 25 | $72.9M | $-2.4M | ||
| Q4 24 | $-11.8M | — | ||
| Q3 24 | $131.1M | $-2.1M | ||
| Q2 24 | $62.1M | $-1.1M | ||
| Q1 24 | $131.1M | $-22.0M |
毛利率LNTHVNET
| Q4 25 | 59.2% | — | ||
| Q3 25 | 57.9% | 20.9% | ||
| Q2 25 | 63.8% | — | ||
| Q1 25 | 63.8% | 25.2% | ||
| Q4 24 | 63.5% | — | ||
| Q3 24 | 63.9% | 23.2% | ||
| Q2 24 | 64.9% | 21.3% | ||
| Q1 24 | 65.4% | 21.6% |
营业利润率LNTHVNET
| Q4 25 | 19.0% | — | ||
| Q3 25 | 11.4% | 0.5% | ||
| Q2 25 | 23.3% | — | ||
| Q1 25 | 27.4% | 0.1% | ||
| Q4 24 | 29.1% | — | ||
| Q3 24 | 35.3% | 24.5% | ||
| Q2 24 | 26.1% | 0.2% | ||
| Q1 24 | 28.8% | 0.2% |
净利率LNTHVNET
| Q4 25 | 13.3% | — | ||
| Q3 25 | 7.2% | -10.7% | ||
| Q2 25 | 20.8% | — | ||
| Q1 25 | 19.6% | -0.8% | ||
| Q4 24 | -3.0% | — | ||
| Q3 24 | 34.6% | -0.7% | ||
| Q2 24 | 15.8% | -0.4% | ||
| Q1 24 | 35.4% | -8.4% |
每股收益（稀释后）LNTHVNET
| Q4 25 | $0.86 | — | ||
| Q3 25 | $0.41 | — | ||
| Q2 25 | $1.12 | — | ||
| Q1 25 | $1.02 | — | ||
| Q4 24 | $-0.18 | — | ||
| Q3 24 | $1.79 | — | ||
| Q2 24 | $0.88 | — | ||
| Q1 24 | $1.87 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $359.1M | $492.1M |
| 总债务越低越好 | $568.7M | — |
| 股东权益账面价值 | $1.1B | $890.8M |
| 总资产 | $2.2B | $6.1B |
| 负债/权益比越低杠杆越低 | 0.52× | — |
8季度趋势，按日历期对齐
现金及短期投资LNTHVNET
| Q4 25 | $359.1M | — | ||
| Q3 25 | $382.0M | $492.1M | ||
| Q2 25 | $695.6M | — | ||
| Q1 25 | $938.5M | $544.3M | ||
| Q4 24 | $912.8M | — | ||
| Q3 24 | $866.4M | $219.5M | ||
| Q2 24 | $757.0M | $247.2M | ||
| Q1 24 | $718.3M | $246.9M |
总债务LNTHVNET
| Q4 25 | $568.7M | — | ||
| Q3 25 | $567.9M | — | ||
| Q2 25 | $566.8M | — | ||
| Q1 25 | $566.1M | — | ||
| Q4 24 | $565.3M | — | ||
| Q3 24 | $613.0K | $1.2B | ||
| Q2 24 | $563.2M | — | ||
| Q1 24 | $562.5M | — |
股东权益LNTHVNET
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $890.8M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | $927.8M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | $902.9M | ||
| Q2 24 | $1.0B | $900.6M | ||
| Q1 24 | $945.5M | $895.1M |
总资产LNTHVNET
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.3B | $6.1B | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.1B | $5.4B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | $4.3B | ||
| Q2 24 | $1.9B | $4.0B | ||
| Q1 24 | $1.8B | $3.9B |
负债/权益比LNTHVNET
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.49× | — | ||
| Q1 25 | 0.49× | — | ||
| Q4 24 | 0.52× | — | ||
| Q3 24 | 0.00× | 1.28× | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.59× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $90.2M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $81.4M | $-193.1M |
| 自由现金流率自由现金流/营收 | 20.0% | -53.2% |
| 资本支出强度资本支出/营收 | 2.2% | 84.6% |
| 现金转化率经营现金流/净利润 | 1.67× | — |
| 过去12个月自由现金流最近4个季度 | $354.1M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流LNTHVNET
| Q4 25 | $90.2M | — | ||
| Q3 25 | $105.3M | $113.8M | ||
| Q2 25 | $87.1M | — | ||
| Q1 25 | $107.6M | $27.0M | ||
| Q4 24 | $157.7M | — | ||
| Q3 24 | $175.1M | $108.3M | ||
| Q2 24 | $84.7M | $55.8M | ||
| Q1 24 | $127.2M | $37.1M |
自由现金流LNTHVNET
| Q4 25 | $81.4M | — | ||
| Q3 25 | $94.7M | $-193.1M | ||
| Q2 25 | $79.1M | — | ||
| Q1 25 | $98.8M | $-220.0M | ||
| Q4 24 | $141.4M | — | ||
| Q3 24 | $159.3M | $-95.0M | ||
| Q2 24 | $73.5M | $-81.6M | ||
| Q1 24 | $119.0M | $-102.2M |
自由现金流率LNTHVNET
| Q4 25 | 20.0% | — | ||
| Q3 25 | 24.7% | -53.2% | ||
| Q2 25 | 20.9% | — | ||
| Q1 25 | 26.5% | -71.1% | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 42.0% | -31.4% | ||
| Q2 24 | 18.7% | -29.8% | ||
| Q1 24 | 32.2% | -38.9% |
资本支出强度LNTHVNET
| Q4 25 | 2.2% | — | ||
| Q3 25 | 2.8% | 84.6% | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.3% | 79.8% | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 4.2% | 67.3% | ||
| Q2 24 | 2.8% | 50.1% | ||
| Q1 24 | 2.2% | 53.0% |
现金转化率LNTHVNET
| Q4 25 | 1.67× | — | ||
| Q3 25 | 3.79× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 1.47× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.34× | — | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
VNET
暂无分部数据
